Librium and Cogentin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Librium (chlordiazepoxide hydrochloride) and Cogentin (benztropine mesylate). Common drug interactions include pancreatitis among females and neuroleptic malignant syndrome among males.
The phase IV clinical study analyzes what interactions people have when they take Librium and Cogentin. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.
What is Librium?
Librium has active ingredients of chlordiazepoxide hydrochloride. It is often used in stress and anxiety. eHealthMe is studying from 2,490 Librium users. Check the latest studies of Librium.
What is Cogentin?
Cogentin has active ingredients of benztropine mesylate. It is often used in tardive dyskinesia. eHealthMe is studying from 7,692 Cogentin users. Check the latest studies of Cogentin.
14 people who take Librium and Cogentin together, and have interactions are studied.

What are the common drug interactions of Librium and Cogentin, by gender? *:
female:
- Pancreatitis (inflammation of pancreas)
- Pharyngolaryngeal pain
- Respiratory tract congestion (blockage on respiratory system)
- Abdominal pain
- Abnormal behaviour
- Aneurysm (enlargement of an artery caused by a weakening of the artery wall)
- Apnoea (suspension of external breathing)
- Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
- Confusional state
- Costochondritis (chest wall pain)
male:
- Neuroleptic malignant syndrome (a life-threatening neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic agents)
- Attention deficit/hyperactivity disorder
- Panic attack
- Parkinson's disease
- Post-traumatic stress disorder
- Pruritus (severe itching of the skin)
- Pyrexia (fever)
- Restless legs syndrome (a powerful urge to move your legs)
- Type 2 diabetes mellitus
- Urticaria (rash of round, red welts on the skin that itch intensely)
What are the common drug interactions of Librium and Cogentin, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
- Pyrexia (fever)
- Type 2 diabetes mellitus
- Acute hepatic failure
- Anaemia macrocytic (a macrocytic class of anaemia)
- Blood creatine phosphokinase increased
- Chills (felling of cold)
- Crepitations (noises are produced by the rubbing of parts one against the other)
- Delirium (wild excitement)
- Disorientation (disability in which the senses of time, direction, and recognition of people and places)
30-39:
- Postnasal drip
- Productive cough
- Pupils unequal
- Respiratory arrest (cessation of normal respiration due to failure of the lungs to function effectively)
- Respiratory depression (respiration has a rate below 12 breaths)
- Respiratory distress (difficulty in breathing)
- Sensation of pressure in ear
- Tongue disorder (disease of tongue)
- Ulcer
- Vomiting
40-49:
- Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
- Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
- Diabetic neuropathy (neuropathic disorders that are associated with diabetes mellitus)
- Dyslipidaemia (abnormal amount of lipids)
- Hyperglycaemia (high blood sugar)
- Hyperlipidaemia (presence of excess lipids in the blood)
- Impaired gastric emptying
- Neuropathy peripheral (surface nerve damage)
- Obesity (having too much body fat)
- Pancreatitis acute (sudden inflammation of pancreas)
50-59:
n/a
60+:
- Parkinsonism (degenerative disorder of the central nervous system characterized by tremor and impaired muscular coordination)
What are the existing conditions these people have? *
- Pain: 8 people, 57.14%
- Depression: 5 people, 35.71%
- Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 4 people, 28.57%
- Bipolar Disorder (mood disorder): 3 people, 21.43%
- Agitation (state of anxiety or nervous excitement): 2 people, 14.29%
- Parkinson's Disease: 2 people, 14.29%
- Thinking Abnormal: 1 person, 7.14%
- High Blood Pressure: 1 person, 7.14%
- Alcohol Withdrawal Syndrome: 1 person, 7.14%
- Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 1 person, 7.14%
* Approximation only. Some reports may have incomplete information.
Do you take Librium and Cogentin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Librium and Cogentin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Librium:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Cogentin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Librium and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Cogentin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on chlordiazepoxide hydrochloride and benztropine mesylate (the active ingredients of Librium and Cogentin, respectively), and Librium and Cogentin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Vicodin Es and Exhaustion, Fatigue, Lethargy, Tiredness, Weariness for Men aged 40-49 - 2 seconds ago
- Vicodin Es and Weariness for Men aged 40-49 - 2 seconds ago
- Vicodin Es and Tiredness for Men aged 40-49 - 2 seconds ago
- Vicodin Es and Lethargy for Men aged 40-49 - 3 seconds ago
- Vicodin Es and Exhaustion for Men aged 40-49 - 3 seconds ago
- Vicodin Es and Fatigue for Men aged 40-49 - 3 seconds ago
- Could Lupron Depot cause Anorexia? - 4 seconds ago
- Could Wellbutrin cause Spinal Cord Compression? - 7 seconds ago
- Lamictal and Tessalon drug interactions for women aged 50-59 - 8 seconds ago
- Intervertebral Disc Degeneration and drugs of ingredients of alpha - lipoic acid - 11 seconds ago